Atlas Trials

Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy

Clinical trial NCT04813380 · COMPLETED

Trial details

NCT number
NCT04813380
Sponsor
Zagazig University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Effects of Immunotherapy
Start date
2021-07-27
Primary completion
2022-09-10
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.